FRESENIUS MEDICAL CARE AG (1FME.MI) Stock Analyst Earnings Estimates
BIT:1FME - Euronext Milan - DE0005785802 - Common Stock - Currency: EUR
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 19.398B 10.10% | 19.454B 0.29% | 19.336B -0.61% | 20.313B 5.05% | 21.106B 3.90% | 22.012B 4.29% | 22.611B 2.72% | 23.344B 3.24% | 23.21B -0.57% | 24.029B 3.53% | 24.885B 3.56% | |
| EBITDA YoY % growth | 3.125B -8.15% | 3.03B -3.03% | 3.008B -0.73% | 3.713B 23.43% | 3.97B 6.92% | 4.201B 5.82% | 4.214B 0.31% | 4.119B -2.25% | 4.732B 14.88% | 4.927B 4.12% | 5.11B 3.71% | |
| EBIT YoY % growth | 1.287B -27.66% | 1.278B -0.65% | 1.266B -0.97% | 2.152B 69.99% | 2.375B 10.36% | 2.555B 7.58% | 2.743B 7.36% | 2.792B 1.79% | 2.838B 1.65% | 3.014B 6.20% | 3.123B 3.62% | |
| Operating Margin | 6.63% | 6.57% | 6.55% | 10.59% | 11.25% | 11.61% | 12.13% | 11.96% | 12.23% | 12.54% | 12.55% | |
| EPS YoY % growth | 3.10 -10.14% | 2.57 -17.23% | 3.25 26.66% | 3.73 14.77% | 4.13 10.61% | 4.75 15.21% | 5.08 6.79% | 5.02 -1.05% | 6.29 25.33% | N/A | N/A |
All data in EUR
| Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | |
|---|---|---|---|---|
| EPS Q2Q % growth | 0.72 -12.60% | 0.83 19.15% | 0.54 -34.72% | 0.58 -36.74% |
| Revenue Q2Q % growth | 4.782B 1.22% | 5.218B 9.48% | 5.26B 10.50% | 4.552B -10.48% |
| EBITDA Q2Q % growth | 580.51M -21.26% | 1.287B -0.67% | 1.288B -23.85% | -78.915M -104.02% |
| EBIT Q2Q % growth | 326.55M 45.24% | 714.13M 80.22% | 801.79M 88.14% | 73.598M -66.34% |
All data in EUR
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q4 2024 Q2Q % growth | 0.91 3.41% | 0.79 | 0.12 | 15.03% |
| Q3 2024 Q2Q % growth | 0.82 43.86% | 0.65 | 0.17 | 25.81% |
| Q2 2024 Q2Q % growth | 0.70 17.45% | 0.68 | 0.02 | 2.71% |
| Q1 2024 Q2Q % growth | 0.82 57.69% | 0.60 | 0.22 | 37.27% |
| Q4 2023 Q2Q % growth | 0.88 2.33% | 0.94 | -0.06 | -6.11% |
| Q3 2023 Q2Q % growth | 0.57 -27.85% | 0.52 | 0.05 | 9.44% |
| Q2 2023 Q2Q % growth | 0.60 -22.60% | 0.51 | 0.09 | 16.93% |
| Q1 2023 Q2Q % growth | 0.52 -23.53% | 0.52 | 0.00 | -0.29% |
| Q4 2022 Q2Q % growth | 0.86 -4.44% | 0.79 | 0.07 | 8.43% |
| Q3 2022 Q2Q % growth | 0.79 -15.96% | 0.68 | 0.11 | 15.76% |
| Q2 2022 Q2Q % growth | 0.77 1.32% | 0.83 | -0.06 | -7.29% |
| Q1 2022 Q2Q % growth | 0.68 -20.00% | 0.70 | -0.02 | -2.50% |
| Q4 2021 Q2Q % growth | 0.90 -29.13% | 0.88 | 0.02 | 2.03% |
| Q3 2021 Q2Q % growth | 0.94 -22.31% | 0.92 | 0.02 | 2.46% |
| Q2 2021 Q2Q % growth | 0.76 -36.67% | 0.76 | 0.00 | 0.20% |
| Q1 2021 Q2Q % growth | 0.85 -10.53% | 0.80 | 0.05 | 5.83% |
| Q4 2020 Q2Q % growth | 1.27 -6.62% | 1.21 | 0.06 | 4.92% |
| Q3 2020 Q2Q % growth | 1.21 | 1.16 | 0.05 | 4.36% |
| Q2 2020 Q2Q % growth | 1.20 30.43% | 1.09 | 0.11 | 10.07% |
| Q1 2020 Q2Q % growth | 0.95 -8.65% | 0.87 | 0.08 | 8.84% |
| Q4 2019 Q2Q % growth | 1.36 | 1.32 | 0.04 | 2.79% |
| Q3 2019 Q2Q % growth | 1.21 | 1.09 | 0.12 | 11.31% |
| Q2 2019 Q2Q % growth | 0.92 | 0.97 | -0.05 | -4.96% |
| Q1 2019 Q2Q % growth | 1.04 | 0.93 | 0.11 | 11.29% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q4 2024 Q2Q % growth | 5.085B 1.94% | 4.795B | 290M | 6.05% |
| Q3 2024 Q2Q % growth | 4.76B -3.57% | 4.979B | -219M | -4.40% |
| Q2 2024 Q2Q % growth | 4.766B -1.23% | 5.014B | -248M | -4.95% |
| Q1 2024 Q2Q % growth | 4.725B 0.43% | 4.681B | 43.522M | 0.93% |
| Q4 2023 Q2Q % growth | 4.988B -0.18% | 5.002B | -14M | -0.28% |
| Q3 2023 Q2Q % growth | 4.936B -3.14% | 4.952B | -15.763M | -0.32% |
| Q2 2023 Q2Q % growth | 4.825B 1.44% | 4.824B | 1.276M | 0.03% |
| Q1 2023 Q2Q % growth | 4.704B 3.43% | 4.767B | -62.782M | -1.32% |
| Q4 2022 Q2Q % growth | 4.997B 7.53% | 5.054B | -57.198M | -1.13% |
| Q3 2022 Q2Q % growth | 5.096B 14.74% | 5.093B | 3.166M | 0.06% |
| Q2 2022 Q2Q % growth | 4.757B 10.10% | 4.811B | -54.32M | -1.13% |
| Q1 2022 Q2Q % growth | 4.548B 8.03% | 4.516B | 32.369M | 0.72% |
| Q4 2021 Q2Q % growth | 4.647B 5.61% | 4.654B | -6.976M | -0.15% |
| Q3 2021 Q2Q % growth | 4.441B 0.63% | 4.517B | -75.634M | -1.67% |
| Q2 2021 Q2Q % growth | 4.32B -5.20% | 4.363B | -42.83M | -0.98% |
| Q1 2021 Q2Q % growth | 4.21B -6.19% | 4.272B | -61.875M | -1.45% |
| Q4 2020 Q2Q % growth | 4.4B -3.93% | 4.495B | -94.846M | -2.11% |
| Q3 2020 Q2Q % growth | 4.414B -0.12% | 4.439B | -25.232M | -0.57% |
| Q2 2020 Q2Q % growth | 4.557B 4.89% | 4.504B | 53.345M | 1.18% |
| Q1 2020 Q2Q % growth | 4.488B 8.60% | 4.466B | 21.796M | 0.49% |
| Q4 2019 Q2Q % growth | 4.58B | 4.628B | -48.037M | -1.04% |
| Q3 2019 Q2Q % growth | 4.419B | 4.461B | -41.997M | -0.94% |
| Q2 2019 Q2Q % growth | 4.345B | 4.395B | -49.968M | -1.14% |
| Q1 2019 Q2Q % growth | 4.133B | 4.151B | -18.443M | -0.44% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 17.29% | N/A | 5.94% | 5.3% |
| Revenue | 1.4% | N/A | 0% | -1.29% |